Impact of Exercise on Body Composition in Premature Infants
NCT ID: NCT01386190
Last Updated: 2021-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2011-06-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Body composition
2. Associated biochemical and cellular mechanisms of growth and inflammation
3. Quality of maternal care will be measured
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assisted Exercise in Prematurity; Effects and Mechanisms
NCT00580099
Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.
NCT03504215
Use of a Tummy Time Intervention and Parent Education in Infants Born Preterm
NCT03759119
Effects of Early Physiotherapy Program on the Infants in NICU
NCT07201792
The Effect of Daily Exercise Program on Bone Mineral Density and Cortisol Level in Preterm Infants
NCT03773679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The challenges are substantial and include:
* measuring body composition
* assessing physical activity
* engaging caregivers as partners in the intervention
* identifying plausible and testable biological mechanisms
* designing interventions that actually increase physical activity and match the rapid pace of motor development early in life
A developmentally dynamic physical activity intervention has been designed and pilot tested-one that engages the caregiver as a partner. Using techniques and tools as far-ranging as Dual X-ray Absorbiometry (DXA), smart phones, doubly labeled water, and lightweight, wireless accelerometers developed specifically for this purpose, the working hypothesis is that the one-year intervention will augment lean body mass (primary outcome variable) and improve bone mineralization and the ratio of lean to fat tissue (secondary outcome variables). The study will gauge the impact of the physical activity intervention on the balance between circulating anabolic mediators (insulin-like growth factor-I and growth hormone binding protein) and inflammation-associated cytokines (interleukin-6, and interleukin-1 receptor antagonist), which antagonize muscle and bone growth.
We will additionally:
1. begin to explore how physical activity influences circulating endothelial progenitor cells, which are increasingly viewed as markers of vascular health very early in life
2. take advantage of this prospective, interventional study to explore potential genetic determinants of growth in babies born prematurely.
3. Finally, any study involving the premature infant and the data associated with it must be viewed in light of the critical relationship between the mother and baby.
The potential broad impact of early life interventions has been recently demonstrated by the success of the "Back-To-Sleep" campaign in mitigating sudden infant death syndrome. Should the positive effects of augmented exercise on body composition be supported, we would then anticipate widespread benefit in preventing long-term health consequences of prematurity at relatively low cost.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Group
Caregivers will be taught progressive exercises to use with their infants from hospital discharge to 1 year of age.
Exercise/Social Behavioral
Both the control and the intervention groups will be guided in implementing structured social interaction. In the intervention group, the structured interaction will incorporate augmented physical activities, while in the control group, the structured interaction will consist of predominantly social activities such as the caregiver reading or singing to the baby. The duration of the structured activities for both groups will be the same.
Control
Both the control and the intervention groups will be guided in implementing structured social interaction.In the control group, the structured interaction will consist of predominantly social activities such as the caregiver reading or singing to the baby. The duration of the structured activities for both groups will be the same.
Exercise/Social Behavioral
Both the control and the intervention groups will be guided in implementing structured social interaction. In the intervention group, the structured interaction will incorporate augmented physical activities, while in the control group, the structured interaction will consist of predominantly social activities such as the caregiver reading or singing to the baby. The duration of the structured activities for both groups will be the same.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise/Social Behavioral
Both the control and the intervention groups will be guided in implementing structured social interaction. In the intervention group, the structured interaction will incorporate augmented physical activities, while in the control group, the structured interaction will consist of predominantly social activities such as the caregiver reading or singing to the baby. The duration of the structured activities for both groups will be the same.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caregiver ≥18 years of age
* Infant gestational age at birth \<29weeks
* Infant gestational age at time of study recruitment \>34 wks, on full feeds and nearing discharge
Exclusion Criteria
* Significant intraventricular hemorrhage, grade III -IV
* Necrotizing entrocolitis
* Tracheostomy
* Bone Diseases
* Osteogenesis Imperfecta
* Hip or knee joint anomalies
* Arthrogryposis
* Fractures
* Skin disorders (e.g., Erythematus Bullosis)
* Symptomatic congestive heart disease
* Any other conditions or congenital anomalies likely to severely impact the ability of the premature baby and caregiver to participate in a demanding study
29 Weeks
34 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan M. Cooper, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Irvine Douglas Hospital
Orange, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS # 2011-8156
Identifier Type: OTHER
Identifier Source: secondary_id
R01H110163-01A1 [2011-8156]
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.